Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
LivaNova PLC - Ordinary Shares
(NQ:
LIVN
)
62.38
-2.03 (-3.15%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
319,999
Open
63.95
Bid (Size)
60.80 (100)
Ask (Size)
63.97 (100)
Prev. Close
64.41
Today's Range
62.16 - 63.99
52wk Range
32.48 - 65.57
Shares Outstanding
49,023,767
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
LivaNova to Present at J.P. Morgan Healthcare Conference in January
December 23, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
December 03, 2025
From
LivaNova PLC
Via
Business Wire
Performance
YTD
+2.9%
+2.9%
1 Month
-0.6%
-0.6%
3 Month
+20.5%
+20.5%
6 Month
+41.9%
+41.9%
1 Year
+31.8%
+31.8%
More News
Read More
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
December 02, 2025
From
LivaNova PLC
Via
Business Wire
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
LivaNova to Present at Piper Sandler Healthcare Conference in December
November 25, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
November 24, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
November 12, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova PLC (NASDAQ:LIVN) Beats Q3 2025 Estimates and Raises Full-Year Guidance
↗
November 05, 2025
Via
Chartmill
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
November 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Wolfe Research Healthcare Conference in November
October 23, 2025
From
LivaNova PLC
Via
Business Wire
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
October 13, 2025
Via
MarketMinute
LivaNova to Announce Third-Quarter 2025 Results
October 08, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
October 07, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Appoints Donald Zurbay as a New Director
September 04, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Host Investor Day on November 12, 2025
August 25, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
August 22, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Launches Essenz Perfusion System in China
August 18, 2025
From
LivaNova PLC
Via
Business Wire
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday
↗
August 06, 2025
Via
Benzinga
LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance
August 06, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Second-Quarter 2025 Results
July 09, 2025
From
LivaNova PLC
Via
Business Wire
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
June 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
June 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
June 04, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Jefferies Global Healthcare Conference
May 15, 2025
From
LivaNova PLC
Via
Business Wire
Frequently Asked Questions
Is LivaNova PLC - Ordinary Shares publicly traded?
Yes, LivaNova PLC - Ordinary Shares is publicly traded.
What exchange does LivaNova PLC - Ordinary Shares trade on?
LivaNova PLC - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for LivaNova PLC - Ordinary Shares?
The ticker symbol for LivaNova PLC - Ordinary Shares is LIVN on the Nasdaq Stock Market
What is the current price of LivaNova PLC - Ordinary Shares?
The current price of LivaNova PLC - Ordinary Shares is 62.38
When was LivaNova PLC - Ordinary Shares last traded?
The last trade of LivaNova PLC - Ordinary Shares was at 01/12/26 04:00 PM ET
What is the market capitalization of LivaNova PLC - Ordinary Shares?
The market capitalization of LivaNova PLC - Ordinary Shares is 3.06B
How many shares of LivaNova PLC - Ordinary Shares are outstanding?
LivaNova PLC - Ordinary Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
